ClinicalTrials.Veeva

Menu

EC-MOTION : ExtraCorporeal Membrane Oxygenation and Therapeutic Drug Monitoring of Drugs of infectION

R

Rennes University Hospital

Status

Unknown

Conditions

Infection

Treatments

Other: blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT02917486
35RC15_8901

Details and patient eligibility

About

The objective of the study is to investigate the exposure difference between antibiotic studied patients in intensive care with Extracorporeal Membrane Oxygenation and patients without Extracorporeal Membrane Oxygenation.

The exhibition is evaluated by population pharmacokinetic modeling.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 18 years
  • Hospitalisation in intensive care
  • Treatment with ECMO or without ECMO
  • Introducing sepsis treated with an anti-infective molecule studied (piperacillin) for less than 48 hours
  • With an arterial catheter
  • Patient Information or their next of kin according to the patients status.

Exclusion criteria

  • Pregnancy
  • Major person under legal protection (backup justice, trusteeship, quardianship), person deprived of liberty

Trial design

60 participants in 2 patient groups

ECMO piperacillin
Description:
patients in intensive care treated with ECMO with antiinfective therapy : piperacillin
Treatment:
Other: blood sample
without ECMO piperacillin
Description:
patients in intensive care without ECMO with antiinfective therapy : piperacillin
Treatment:
Other: blood sample

Trial contacts and locations

1

Loading...

Central trial contact

Anne Ganivet; Pierre Fillatre

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems